{
    "organizations": [],
    "uuid": "14e785d3b3687e793eefeecf5603269c93381da1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eagle-pharmaceuticals-gets-final-f/brief-eagle-pharmaceuticals-gets-final-fda-approval-for-bendamustine-hydrochloride-ready-to-dilute-solution-in-500ml-admixture-idUSASC0A2JW",
    "ord_in_thread": 0,
    "title": "BRIEF-Eagle Pharmaceuticals Gets Final FDA Approval For Bendamustine Hydrochloride Ready-To-Dilute Solution In 500Ml Admixture",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - Eagle Pharmaceuticals Inc:\n* EAGLE PHARMACEUTICALS INC GRANTED FINAL FDA APPROVAL FOR BENDAMUSTINE HYDROCHLORIDE READY-TO-DILUTE SOLUTION IN A 500ML ADMIXTURE\n* SAYS EAGLE TO SHIP 500ML ADMIXTURE PRODUCT IMMEDIATELY Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-16T19:01:00.000+03:00",
    "crawled": "2018-05-17T14:46:18.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eagle",
        "pharmaceutical",
        "inc",
        "eagle",
        "pharmaceutical",
        "inc",
        "granted",
        "final",
        "fda",
        "approval",
        "bendamustine",
        "hydrochloride",
        "solution",
        "500ml",
        "admixture",
        "say",
        "eagle",
        "ship",
        "500ml",
        "admixture",
        "product",
        "immediately",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}